Education
About Us
Working with TipRanks
Follow Us
Guard Therapeutics International AB (SE:GUARD)
:GUARD
RESEARCH TOOLSreports
GUARD Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr11.85 - kr38.17
Previous CloseN/A
Volume1.94K
Average Volume (3M)27.83K
Market Cap
kr307.56M
Enterprise ValueN/A
Total Cash (Recent Filing)kr54.19M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-1.02
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.78
Shares Outstanding20,167,631
10 Day Avg. Volume29,646
30 Day Avg. Volume27,829
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)6.48
Price to Sales (P/S)0.00
P/FCF Ratio-2.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
GUARD FAQ
What was Guard Therapeutics International AB’s price range in the past 12 months?
Guard Therapeutics International AB lowest stock price was kr11.85 and its highest was kr38.17 in the past 12 months.
What is Guard Therapeutics International AB’s market cap?
Guard Therapeutics International AB’s market cap is kr307.56M.
When is Guard Therapeutics International AB’s upcoming earnings report date?
Guard Therapeutics International AB’s upcoming earnings report date is Aug 21, 2025 which is in 94 days.
How were Guard Therapeutics International AB’s earnings last quarter?
Guard Therapeutics International AB released its earnings results on May 07, 2025. The company reported -kr2.783 earnings per share for the quarter, missing the consensus estimate of N/A by -kr2.783.
Is Guard Therapeutics International AB overvalued?
According to Wall Street analysts Guard Therapeutics International AB’s price is currently Overvalued.
Does Guard Therapeutics International AB pay dividends?
Guard Therapeutics International AB does not currently pay dividends.
What is Guard Therapeutics International AB’s EPS estimate?
Guard Therapeutics International AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Guard Therapeutics International AB have?
Guard Therapeutics International AB has 20,167,631 shares outstanding.
What happened to Guard Therapeutics International AB’s price movement after its last earnings report?
Guard Therapeutics International AB reported an EPS of -kr2.783 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.348%.
Which hedge fund is a major shareholder of Guard Therapeutics International AB?
Currently, no hedge funds are holding shares in SE:GUARD
---
Company Description
Guard Therapeutics International AB
Guard Therapeutics International AB (GUARD) is a biopharmaceutical company focused on developing innovative therapies to protect and restore organ function in patients with acute kidney injury (AKI) and other conditions. The company is headquartered in Sweden and operates primarily in the biotechnology and medical research sectors. Its core product is ROSgard, a drug candidate designed to reduce tissue damage and preserve organ function.
---
Technical Analysis
Oncopeptides AB
―
Cantargia AB
―
Immunicum AB
―
Intervacc AB
―
Xbrane Biopharma AB
―
---